Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 12
2005 9
2006 7
2007 3
2008 13
2009 7
2010 8
2011 15
2012 12
2013 21
2014 15
2015 15
2016 11
2017 14
2018 15
2019 18
2020 24
2021 20
2022 12
2023 18
2024 22
2025 33
2026 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

304 results

Results by year

Filters applied: . Clear all
Page 1
Retina as a potential biomarker in schizophrenia spectrum disorders: a systematic review and meta-analysis of optical coherence tomography and electroretinography.
Komatsu H, Onoguchi G, Silverstein SM, Jerotic S, Sakuma A, Kanahara N, Kakuto Y, Ono T, Yabana T, Nakazawa T, Tomita H. Komatsu H, et al. Among authors: silverstein sm. Mol Psychiatry. 2024 Feb;29(2):464-482. doi: 10.1038/s41380-023-02340-4. Epub 2023 Dec 11. Mol Psychiatry. 2024. PMID: 38081943 Free PMC article.
Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy.
Ipp E, Liljenquist D, Bode B, Shah VN, Silverstein S, Regillo CD, Lim JI, Sadda S, Domalpally A, Gray G, Bhaskaranand M, Ramachandra C, Solanki K; EyeArt Study Group. Ipp E, et al. Among authors: silverstein s. JAMA Netw Open. 2021 Nov 1;4(11):e2134254. doi: 10.1001/jamanetworkopen.2021.34254. JAMA Netw Open. 2021. PMID: 34779843 Free PMC article. Clinical Trial.
Oculomics in Schizophrenia Research.
Silverstein SM, Keane BP, Corlett PR. Silverstein SM, et al. Schizophr Bull. 2021 Apr 29;47(3):577-579. doi: 10.1093/schbul/sbab011. Schizophr Bull. 2021. PMID: 33606022 Free PMC article. No abstract available.
Association Between Retinal Features From Multimodal Imaging and Schizophrenia.
Wagner SK, Cortina-Borja M, Silverstein SM, Zhou Y, Romero-Bascones D, Struyven RR, Trucco E, Mookiah MRK, MacGillivray T, Hogg S, Liu T, Williamson DJ, Pontikos N, Patel PJ, Balaskas K, Alexander DC, Stuart KV, Khawaja AP, Denniston AK, Rahi JS, Petzold A, Keane PA. Wagner SK, et al. Among authors: silverstein sm. JAMA Psychiatry. 2023 May 1;80(5):478-487. doi: 10.1001/jamapsychiatry.2023.0171. JAMA Psychiatry. 2023. PMID: 36947045 Free PMC article.
The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures.
Mathalon DH, Nicholas S, Roach BJ, Billah T, Lavoie S, Whitford T, Hamilton HK, Addamo L, Anohkin A, Bekinschtein T, Belger A, Buccilli K, Cahill J, Carrión RE, Damiani S, Dzafic I, Ebdrup BH, Izyurov I, Jarcho J, Jenni R, Jo A, Kerins S, Lee C, Martin EA, Mayol-Troncoso R, Niznikiewicz MA, Parvaz M, Pogarell O, Prieto-Montalvo J, Rabin R, Roalf DR, Rogers J, Salisbury DF, Shaik R, Shankman S, Stevens MC, Suen YN, Swann NC, Tang X, Thompson JL, Tso I, Wenzel J, Zhou JH, Addington J, Alameda L, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Castillo-Passi RI, Chen EYH, Choi J, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim M, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Mamah D, Mittal VA, Nordentoft M, Pearlson GD, Perez J, Perkins DO, Powers AR, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Stone WS, Strauss GP, Upthegrove R, Verma SK, Wang J, Wolf DH, Zhang T, Bouix S, Pasternak O, Cho KK, Coleman MJ, Dwyer D, Nunez A, Tamayo Z, Wood SJ, Kahn RS, Kane JM, McGorry PD, Bearden CE, Nelson B, Woods SW, Shenton ME; Ac… See abstract for full author list ➔ Mathalon DH, et al. Among authors: silverstein sm. Schizophrenia (Heidelb). 2025 Jun 6;11(1):85. doi: 10.1038/s41537-025-00622-0. Schizophrenia (Heidelb). 2025. PMID: 40480970 Free PMC article.
Genetic susceptibility to schizophrenia through neuroinflammatory pathways associated with retinal thinness.
Rabe F, Smigielski L, Georgiadis F, Kallen N, Omlor W, Edkins V, Kirschner M, Cathomas F, Grünblatt E, Silverstein S, Blose B, Barthelmes D, Schaal K, Rubio J, Lencz T, Homan P. Rabe F, et al. Among authors: silverstein s. Nat Ment Health. 2025;3(5):538-547. doi: 10.1038/s44220-025-00414-6. Epub 2025 Apr 21. Nat Ment Health. 2025. PMID: 40365461 Free PMC article.
Schizophrenia in Translation: Why the Eye?
Silverstein SM, Choi JJ, Green KM, Bowles-Johnson KE, Ramchandran RS. Silverstein SM, et al. Schizophr Bull. 2022 Jun 21;48(4):728-737. doi: 10.1093/schbul/sbac050. Schizophr Bull. 2022. PMID: 35640030 Free PMC article.
Leading Through Rapid Change Management.
Stanz L, Silverstein S, Vo D, Thompson J. Stanz L, et al. Among authors: silverstein s. Hosp Pharm. 2022 Aug;57(4):422-424. doi: 10.1177/00185787211046855. Epub 2021 Sep 16. Hosp Pharm. 2022. PMID: 35898249 Free PMC article. No abstract available.
The association of retinal age gap with schizophrenia: a cross-sectional analysis.
Antaki F, Kerexeta-Sarriegi J, Reis APR, Zhu Z, Chen R, Hu W, Ge Z, Denniston A, Petzold A, Silverstein SM, Keane PA, Wagner SK. Antaki F, et al. Among authors: silverstein sm. Schizophr Res. 2025 Sep;283:180-187. doi: 10.1016/j.schres.2025.07.018. Epub 2025 Jul 24. Schizophr Res. 2025. PMID: 40712190 Free article.
Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program.
Wigman JTW, Ching AE, Chung Y, Eichi HR, Lane E, Langholm C, Vaidyam A, Byun AJS, Haidar A, Hartmann J, Nunez A, Dwyer D, Nasarudin AA, Borders O, Scott I, Tamayo Z, Matneja P, Cho KI, Addington J, Alameda LK, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Chen EYH, Choi J, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim SW, Koutsouleris N, Langbein K, Mamah D, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Perez J, Perkins DO, Powers AR 3rd, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Yassin W, Stone WS, Strauss GP, Thompson JL, Upthegrove R, Verma S, Wang J, Wolf DH, Wolff P; Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ); Rowland LM, D'Alfonso S, Pasternak O, Bouix S, McGorry PD, Kahn RS, Kane JM, Bearden CE, Woods SW, Shenton ME, Nelson B, Baker JT, Torous J. Wigman JTW, et al. Among authors: silverstein sm. Schizophrenia (Heidelb). 2025 Jun 3;11(1):83. doi: 10.1038/s41537-025-00599-w. Schizophrenia (Heidelb). 2025. PMID: 40461469 Free PMC article.
304 results